Protalix BioTherapeutics, Inc. (PLX)

Phillips 66 is expected to release its fiscal Q2 earnings next month, and analysts project significant EPS growth.

Phillips 66 (PSX) closed the most recent trading day at $176.42, moving +1.1% from the previous trading session.

Plexus Corp. (NasdaqGS: PLXS) was recently removed from several Russell value and small-cap benchmarks, including the Russell 3000 Value, Russell 2000 Value, and related composite indices, following the latest index reconstitution. This broad index removal can trigger forced buying and selling ...

Sector peer Edenred, which faces similar Brazilian regulatory exposure, has historically moved in sympathy with Pluxee on earnings days, though no fresh Edenred catalyst was identified today. The stock’s 52-week low of €9.90 and the gap to the average analyst price target reflect how deeply ...

Looking to buy Protalix Biotherapeutics Stock? Get the latest PLX quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.